Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bo-Reum Kim
Institutions:
The Catholic University of Korea Seoul St. Mary's Hospital,
Catholic University of Korea
Observed institutions:
The Catholic University of Korea Seoul St. Mary's Hospital,
Catholic University of Korea
ORCID:
0009-0000-5230-1233
Observed ORCID:
0009-0000-5230-1233
OpenAlex ID:
A5017016256
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently
2023
·
Han Sun Kim
, Bo-Reum Kim
, et al.
·
Blood Advances
·
41
PDF
CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-β Signaling
2020
·
Bo-Reum Kim
, Seung-Hyun Jung
, et al.
·
Cancers
·
21
PDF
Characterization of the Bone Marrow Lymphoid Microenvironment and Discovery of Prognostic Immune-Related Factors in Acute Myeloid Leukemia
2024
·
Yoon-Ju Kim
, Daehun Kwag
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Anti-Leukemic Effects of CK1α Degrader As Monotherapy and in Combination with Targeted Drugs
2023
·
Bo-Reum Kim
, Hyunseok Kang
, et al.
·
Blood
·
1
PDF
Figure S8 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Data from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S6 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S4 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Supplementary Tables from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S5 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S1 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S9 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S7 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S3 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S10 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Figure S2 from A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
Therapeutic Synergy and Immune Activation by SUMOylation Pathway Inhibition in Acute Myeloid Leukemia
2026
·
Hyunsong Son
, Bo-Reum Kim
, et al.
·
Blood Advances
PDF
A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells
2026
·
Bo-Reum Kim
, Hyemin Kim
, et al.
·
Cancer Research
Show more works
View as search
Works count:
18
Citation count:
66
H-index:
3
I10-index:
2
Year
Topic
Type